ENABLEX 7,5 MG COM REV LIB PROL CT BL AL/AL X 28

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1376401410034
  • GGREM 505614120040113
  • Código de barras 7895858015176

O que a fonte publica

Detentor do registro
ASPEN PHARMA INDÚSTRIA FARMACÊUTICA LTDA
Princípios ativos
BROMIDRATO DE DARIFENACINA
Embalagem
7,5 MG COM REV LIB PROL CT BL AL/AL X 28
Tipo de produto
Novo
Classe terapêutica
G4D4 - PRODUTOS PARA INCONTINÊNCIA URINÁRIA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:505614120040113
{
  "name": "ENABLEX 7,5 MG COM REV LIB PROL CT BL AL/AL X 28",
  "holder": "ASPEN PHARMA INDÚSTRIA FARMACÊUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7895858015176"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "505614120040113",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "02.433.631/0001-20",
  "priceRegime": "Regulado",
  "productName": "ENABLEX",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "7,5 MG COM REV LIB PROL CT BL AL/AL X 28",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "225.21",
    "icms-12": "255.92",
    "icms-17": "271.34",
    "icms-18": "274.65",
    "icms-19": "278.04",
    "icms-20": "281.51",
    "icms-21": "285.08",
    "icms-22": "288.73",
    "icms-23": "292.48",
    "icms-17.5": "272.98",
    "icms-19.5": "279.76",
    "icms-20.5": "283.28",
    "icms-22.5": "290.59",
    "icms-12-alc": "228.50",
    "icms-17-alc": "242.27",
    "icms-18-alc": "245.22",
    "icms-19-alc": "248.25",
    "icms-20-alc": "251.35",
    "icms-21-alc": "254.53",
    "icms-22-alc": "257.80",
    "icms-23-alc": "261.14",
    "withoutTaxes": "201.08",
    "icms-17.5-alc": "243.73",
    "icms-19.5-alc": "249.79",
    "icms-20.5-alc": "252.93",
    "icms-22.5-alc": "259.46"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "BROMIDRATO DE DARIFENACINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "302.11",
    "icms-12": "343.31",
    "icms-17": "363.99",
    "icms-18": "368.43",
    "icms-19": "372.98",
    "icms-20": "377.64",
    "icms-21": "382.42",
    "icms-22": "387.32",
    "icms-23": "392.35",
    "icms-17.5": "366.19",
    "icms-19.5": "375.29",
    "icms-20.5": "380.01",
    "icms-22.5": "389.82",
    "icms-12-alc": "315.89",
    "icms-17-alc": "334.92",
    "icms-18-alc": "339.00",
    "icms-19-alc": "343.19",
    "icms-20-alc": "347.48",
    "icms-21-alc": "351.87",
    "icms-22-alc": "356.39",
    "icms-23-alc": "361.01",
    "withoutTaxes": "277.98",
    "icms-17.5-alc": "336.94",
    "icms-19.5-alc": "345.32",
    "icms-20.5-alc": "349.66",
    "icms-22.5-alc": "358.69"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "BROMIDRATO DE DARIFENACINA"
  ],
  "therapeuticClass": "G4D4 - PRODUTOS PARA INCONTINÊNCIA URINÁRIA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1376401410034",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "G4D4",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:505614120040113"